• GW4064: Advanced FXR Agonist Insights for Fibrosis & Metabol

  2026-06-09

  Explore how GW4064, a potent non-steroidal FXR agonist, empowers metabolic and fibrosis research through novel FXR/TLR4 pathway modulation. This article delivers protocol guidance and unique assay insights, surpassing current content with a focus on mechanistic clarity and experimental application.

• NDRG2-Driven DRP1 Phosphorylation Promotes Pulmonary Hyperte

  2026-06-09

  This study reveals that NDRG2 accelerates pulmonary hypertension (PH) by promoting DRP1 phosphorylation, leading to excessive mitochondrial fission and vascular remodeling. These insights highlight the NDRG2-DRP1 axis as a promising therapeutic target for PH and demonstrate the value of precise cell proliferation assessment in vascular research.

• Deep Learning Detects Cardiotoxicity in iPSC-CM Screens

  2026-06-08

  Grafton et al. introduce a deep learning approach to rapidly identify cardiotoxicity in high-content screens using human iPSC-derived cardiomyocytes. This innovation enables scalable, phenotypic drug safety assessment at early stages of drug discovery, with implications for improving predictive cardiac electrophysiology research.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-06-08

  The Aconitase Activity Colorimetric Assay Kit enables rapid, quantitative detection of iron-sulfur protein aconitase activity, serving as a sensitive marker for oxidative damage and mitochondrial function. This kit offers precise colorimetric readouts for citrate-to-isocitrate isomerization, making it ideal for high-throughput TCA cycle enzyme assays and immunometabolism research.

• MLN4924 HCl Salt: Neddylation Pathway Inhibition in Viral Im

  2026-06-07

  Explore how MLN4924 HCl salt, a potent NEDD8-activating enzyme inhibitor, enables advanced investigation of viral modulation of necroptosis and inflammation. This article uncovers new research frontiers for neddylation pathway inhibition in immune signaling and viral-host interactions.

• Cy5-UTP: Fluorescent RNA Labeling for Molecular Biology

  2026-06-06

  Cy5-UTP (Cyanine 5-uridine triphosphate) enables robust, direct RNA labeling during in vitro transcription. Its high photostability and emission at 670 nm facilitate sensitive detection in FISH and dual-color expression arrays.

• In Vitro Susceptibility of Staphylococci to Mupirocin and No

  2026-06-05

  This study systematically evaluates the in vitro activity of mupirocin and novobiocin against meticillin-resistant and meticillin-susceptible staphylococci isolated from both healthy dogs and those with superficial pyoderma. Its findings advance understanding of current antimicrobial options in veterinary dermatology, particularly regarding resistance patterns in canine staphylococcal infections.

• U0126-EtOH: Precision MEK1/2 Inhibition for Advanced Neuropr

  2026-06-05

  Explore how U0126-EtOH, a selective MEK1/2 inhibitor, enables nuanced investigation of MAPK/ERK signaling and neuroprotection against oxidative glutamate toxicity. This article delivers a deeper analysis of mechanistic insights and experimental parameters, distinguishing it from existing guides.

• SINAT Proteins Regulate Autophagic Vesicle Degradation via V

  2026-06-04

  This study elucidates the regulatory mechanism by which SINAT proteins control autophagic vesicle degradation in Arabidopsis, identifying VAB1 as a direct target. The findings provide new insights into plant nutrient stress responses and the modulation of autophagy via ubiquitin-mediated proteolysis.

• Icatibant in Severe Viral Infections: Mechanistic Insights a

  2026-06-04

  This article analyzes recent findings on the use of icatibant, a bradykinin receptor antagonist, in the treatment of severe viral infections such as hantavirus-induced nephropathia epidemica and COVID-19 pneumonia. The key innovation lies in demonstrating the potential for KKS and bradykinin pathway modulation to mitigate vascular permeability and organ dysfunction in critical viral illness, with implications for targeted therapeutic strategies.

• MG-132 (Z-LLL-al): Redefining Oxidative Stress and Proteasom

  2026-06-03

  Explore how MG-132, a potent proteasome inhibitor, uniquely enables advanced studies of oxidative stress, ROS generation, and apoptosis. This article delivers a deeper integration of mechanistic insights and protocol guidance, highlighting innovative applications beyond traditional cell cycle and cancer research assays.

• Latrunculin A (SKU B7555): Reliable Actin Cytoskeleton Disru

  2026-06-03

  This scenario-driven article addresses key laboratory challenges in actin cytoskeleton research by highlighting how Latrunculin A (SKU B7555) from APExBIO offers reproducible, data-backed solutions. Drawing on recent literature and practical protocols, the analysis empowers researchers to optimize cell morphology, motility, and cytotoxicity workflows using this reversible inhibitor of actin assembly.

• SGI-1027 and Everolimus Synergy: Lysosomal Permeability in R

  2026-06-02

  This study uncovers the synergistic effect of SGI-1027 and everolimus in inducing apoptosis and GSDME-dependent pyroptosis in renal cell carcinoma by triggering lysosomal membrane permeability. The findings offer new mechanistic insights and therapeutic strategies to overcome drug resistance in advanced RCC.

• Gramine: Mechanistic Leverage for Translational Ferroptosis

  2026-06-02

  Explore the transformative role of Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a precision ferroptosis inducer in aggressive breast cancer models. This article unpacks the CUL3–MTDH axis, offers detailed protocol guidance, situates Gramine in the competitive research landscape, and charts a translational roadmap for next-generation cancer biology.

• CD28-ARS2 Axis Drives PKM Splicing, Enhancing CD8+ T Cell Me

  2026-06-01

  The referenced study uncovers a novel CD28-ARS2 signaling axis in CD8+ T cells that regulates alternative splicing of pyruvate kinase M (PKM), promoting metabolic flexibility and antitumor immunity. These findings clarify how post-transcriptional control fine-tunes T cell metabolism, with implications for immunometabolic research and assay development.

8594 records 15/573 page Previous Next First page 上5页 1112131415 下5页 Last page